1) o/o emulsion in-liquid drying process
o/o型乳化-液中干燥法
1.
The biodegradable sustained-release microspheres loaded with huperzine A for injection were prepared by o/w and o/o emulsion in-liquid drying process, respectively.
对比研究了o/w型和o/o型乳化-液中干燥法制得微球的形态、粒径和药物体内外释药情况。
2) o/w emulsion in-liquid drying process
o/w型乳化-液中干燥法
3) W/O style emulsion
W/O型乳化液
4) O/O emulsion solvent evaporation method
O/O型乳化溶剂挥发法
1.
Methods Huperzine A-PLGA microspheres were prepared by two kinds of O/O emulsion solvent evaporation method(method A and B).
方法采用两种O/O型乳化溶剂挥发法工艺(A法和B法)制备Hup微球。
5) O/W/O emulsion
O/W/O型乳液
1.
An O/W/O emulsion was prepared by a double-step procedure in which an O/W emulsion was prepared in the first step, and then the O/W emulsion was "re-emulsified" in an oil phase.
我们使用了典型的不稳定型药剂视黄醇(维生素A),考察了O／W/O型乳液中药剂稳定性的效果。
6) O/W emulsions
O/W型乳液
1.
Experimental study on the preparation of O/W emulsions by SPG membrane emulsification;
利用SPG膜制备O/W型乳液实验研究
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条